OTCMKTS:SLTK Solis Tek (SLTK) Stock Price, News & Analysis → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free SLTK Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.88▼$0.9850-Day Range N/A52-Week Range$0.40▼$2.64Volume100,274 shsAverage Volume117,883 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Solis Tek alerts: Email Address Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. About Solis TekGeneration Alpha, Inc. engages in developing, manufacturing, and distribution of digital lighting equipment. It focuses on the research, design, and manufacturing of advanced, energy efficient indoor horticulture lighting, plant nutrient products, and ancillary equipment. The company was founded by Alan Lien and Alvin Hao on March 2, 2007 and is headquartered in Upland, CA.Read More Ad Banyan Hill PublishingREAD THIS – If You Missed Out On The AI BoomAdam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. SLTK Stock News HeadlinesFebruary 24, 2024 | health.usnews.comPaloma B. Solis CariagaDecember 18, 2023 | chicago.suntimes.comProsecutors ‘didn’t have the decency’ to call their key witness in Ed Burke’s corruption trial, defense says in closing argumentsMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.December 18, 2023 | chicago.suntimes.comSo long, Solis? Defense rests in Burke trial after briefly questioning ‘hostile’ witness and FBI mole Danny SolisOctober 5, 2023 | chicago.suntimes.comPolitically connected Chicago Park District manager got slap on the wrist after mishandling a sexual harassment allegationSeptember 10, 2023 | chicago.suntimes.comFeds tell Ed Burke’s lawyers they don’t plan to call Danny Solis at racketeering trialSeptember 6, 2023 | health.usnews.comCynthia S. SolisJune 18, 2023 | health.usnews.comDr. Elena M. Solis GonzalezMay 8, 2024 | Behind the Markets (Ad)Fidelity, Bezos, Goldman Bet Big on Tiny BiotechAre you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.February 5, 2023 | morningstar.comVanguard Emerg Mkts Sel Stk InvOctober 25, 2021 | finance.yahoo.comSolis Tek Applauds California Pesticide Ban for Cannabis CultivationSee More Headlines Receive SLTK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Solis Tek and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2017Today5/08/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorComputer and Technology Industry Miscellaneous Business Services Sub-IndustryN/A Current SymbolOTCMKTS:SLTK CUSIPN/A CIKN/A Webwww.solis-tek.com Phone(888) 998-8881FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesTiffany DavisPresident, CEO, Chief Financial Officer & DirectorJosh ArmitageManager-National SalesKey CompetitorsCornerWorldOTCMKTS:CWRL(UPGI)OTCMKTS:UPGI01 Communique LaboratoryOTCMKTS:OCQLF12 ReTechOTCMKTS:RETC1mage SoftwareOTCMKTS:ISOLView All Competitors SLTK Stock Analysis - Frequently Asked Questions How were Solis Tek's earnings last quarter? Solis Tek Inc. (OTCMKTS:SLTK) announced its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.04) EPS for the quarter. The business had revenue of $1.99 million for the quarter. What other stocks do shareholders of Solis Tek own? Based on aggregate information from My MarketBeat watchlists, some companies that other Solis Tek investors own include Alnylam Pharmaceuticals (ALNY), Alibaba Group (BABA), Toyota Motor (TM), Tencent (TCEHY), Aphria (APHQF), Weyerhaeuser (WY), Aurora Cannabis (ACBFF), Caterpillar (CAT) and Auxly Cannabis Group (CBWTF). This page (OTCMKTS:SLTK) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Solis Tek Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.